Skip to main navigation Skip to search Skip to main content

Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability

  • Sun Ji Park
  • , Sung Woo Lee
  • , Heegyum Moon
  • , Su Min Jung
  • , Jin Man Kim
  • , Dong Seok Lee*
  • , Eui Hwan Choi*
  • *Corresponding author for this work
  • Kyungpook National University
  • Konyang University
  • Korea National University of Transportation

Research output: Contribution to journal › Journal article › peer-review

Abstract

Amphiregulin (AREG) functions as an epidermal growth factor receptor (EGFR) ligand that modulates signaling and supports nuclear processes involved in DNA replication and repair in colorectal cancer (CRC). Immunohistochemistry and western blot revealed high expression of AREG in CRC tumors compared to other CRCs. Our findings indicate that AREG translocates into the nucleus, a process potentially facilitated by the inhibition of endocytosis. Transcriptomic analyses suggest an association between AREG expression and genes regulating EGFR signaling, replication fork dynamics, and homologous recombination. Depletion of AREG via siRNA or CRISPR-Cas9 led to S/G₂ arrest, replication tract shortening, and increased RAD51, RPA, and γH2AX foci, resulting in a 40–60% reduction in proliferation effects that were not fully recapitulated by small-molecule EGFR inhibitors. In xenograft models, AREG knockout reduced tumor growth and suppressed the phosphorylation of EGFR, ERK, STAT3, and BRAF. Furthermore, combining AREG loss with EGFR inhibition appeared to enhance antitumor effects. These findings suggest that AREG may function as a mediator of EGFR signaling and genome maintenance in CRC.

Original languageEnglish
Pages (from-to)2914-2931
Number of pages18
JournalOncogene
Volume45
Issue number29
DOIs
StatePublished - 2026.08.4

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability'. Together they form a unique fingerprint.

Cite this